In Conversation

“ Donald Niesten and Omer Saka discuss the current dynamics of the healthcare and pharmaceutical sectors in Belgium, the challenges of entering the market and the issue… ”

Mr Pasini, before becoming site director of the Verviers plant you were acting as the Head of Investor Relations for Lonza. Can you provide us with…

Can you start by giving our readers a brief overview of the company’s history here and your most notable achievements? Initially the company was founded as…

Although MicroConstants traces its history back to 1998 in San Diego, you co-founded the China operations in 2007. What’s the story behind how that came about?…

Celgene is a relative newcomer to China. What’s the story behind how the company entered the market, and how did you yourself come to manage the…

We last met with you as the head of Zuellig in 2009. Obviously, a lot has changed since then; from both a sector and corporate point…

Deloitte is certainly renowned for its strong network of international expertise in the field of life sciences having teams in all of the crucial markets able…

Deloitte is certainly renowned for its strong network of international expertise in the field of life sciences having teams in all of the crucial markets able…

2012 marks the twentieth anniversary of Polymun. Can you describe to our readers the origins of the company and how it compares to your expectations in…

Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting recent milestones & achievements? George Clinical is an important…

HSA celebrated its 10th anniversary in 2011. How different is the organisation today from when it started? HSA covers the regulation of health products in Singapore.…

2012 represents the 123rd anniversary of Schülke&Mayr. There have been many changes over the years, but do you think the ideals and values of today reflect…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here